Rubicon Research Ltd reports Q2 FY27 revenue of ₹5,764 million, up 39.9% YoY, and raises FY27 operating EBITDA margin guidance to 24%+
- Q2 operating EBITDA margin was 25.0%, versus 22.9% a year earlier; PAT rose 67.9% YoY to ₹904 million.
- Revenue grew 7.9% and PAT 6.6% sequentially; Q2 had no one-off income, compared with ₹36 million of insurance-claim income in Q1.
- FDA observations at several facilities were procedural, with no data-integrity concerns noted.
